More Than Half of Infants Diagnosed With HIV Did Not Receive Postnatal HIV Prophylaxis
By Elana Gotkine HealthDay Reporter
THURSDAY, July 24, 2025 -- Although the rate of perinatal HIV infection is low, more than 50 percent of HIV infections in infants before age 1 year occurred in those who did not receive postnatal prophylaxis, according to a study published online June 17 in Pediatrics.
Mingyue Lu, from the University of Michigan in Ann Arbor, and colleagues conducted a retrospective study using the MarketScan Multi-State Medicaid Database for 2009 to 2021 to provide data on postnatal HIV prophylaxis. Antiretroviral use was identified among infants and classified into single-, double-, and triple-drug prophylactic and therapeutic use.
Overall, 2,304 of the 3,147,318 infants included in the study received postnatal prophylaxis, with 2,123 receiving zidovudine alone. The researchers found that in 2009, zidovudine monotherapy was the only prophylaxis used, but the rate decreased to 71.7 percent by 2021, as the use of combination prophylaxis increased. By 2018, use of triple-drug prophylaxis became more common than double-drug prophylaxis. Overall, 51.9 percent of the 52 infants with HIV infection were diagnosed between 6 weeks and 1 year of life, but had not received postnatal prophylaxis; most of these patients were Black (73.8 percent).
"When newborns aren't getting preventive treatment, it suggests we may be missing HIV infections in pregnant women and missing critical opportunities to intervene," senior author Kengo Inagaki, M.D., also from the University of Michigan, said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Rebound Weight Gain Common After Discontinuing Antiobesity Medications
FRIDAY, July 25, 2025 -- Antiobesity medications (AOMs) yield weight loss during use, followed by weight regain after discontinuation of treatment, according to a review published...
Patients Face High Out-of-Pocket Costs After Incident Cancer Diagnosis
FRIDAY, July 25, 2025 -- Patients face high out-of-pocket costs (OOPCs) after an incident diagnosis of cancer, with costs increasing with stage of diagnosis, according to a study...
Exposure to PFAS Mixtures Linked to Increased Odds of Type 2 Diabetes
FRIDAY, July 25, 2025 -- In multiethnic populations, exposure to per- and polyfluoroalkyl substance (PFAS) mixtures may be associated with increased odds of type 2 diabetes (T2D)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.